View Author
treatment ambisome amphotericin amphotericin b fungizone antifungal survival liposomal lesion infection concentration inoculation aspergillosi liposomal amphotericin b ambisome monotherapy regimen antifungal treatment efficacy chitin group monotherapy animal control model addition liposomes therapy combination nebulized liposomal amb antimicrobial agents treatment regimens agent parameter .... gold-labeled liposomes day 1 combination therapy study liposomal amb chemotherapy aspergillu l-amb antimicrobial liver increase treatment groups aerosol treatment aerosol nebulized journal patient difference content serum lung weight 10 days antifungal activity amb-doc alveolar organ rat model disease ambisome monotherapy group weight fumigatu amphotericin b desoxycholate lung chitin content chitin content blood macroscopic lesions effect administration tissue angio-invasive lesions gm concentration angio-invasive gold-labeled treatment response alveolar macrophages homogenate
2 Most Recent Publications
|
Nebulized amphotericin B combined with intravenous amphotericin B in rats with severe invasive pulmonary aspergillosis.
(Article)
Ruijgrok, E.J. Fens, M.H. Bakker-Woudenberg, I.A.J.M. Etten, E.W.M. van Vulto, A.G. |
2006-05-01
|
|
Enhanced antifungal efficacy in experimental invasive pulmonary aspergillosis by combination of AmBisome with Fungizone as assessed by several parameters of antifungal response
(Article)
Becker, M.J. Marie, S. de Fens, M.H. Hop, W.C.J. Verbrugh, H.A. Bakker-Woudenberg, I.A.J.M. |
2002-01-01
|